# Meiji Seika Pharma Co., Ltd. – FDA Inspection, Jul 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/meiji-seika-pharma-co-ltd/c9e1e8ce-7814-44aa-8c5f-7fb020f0a6e2
Source feed: FDA_Inspections

> FDA inspection 1065559 of Meiji Seika Pharma Co., Ltd., July 20, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1065559
- Company Name: Meiji Seika Pharma Co., Ltd.
- Inspection Date: 2018-07-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 974522 - 2016-06-03
- FDA Inspection 816790 - 2012-12-14

## Related Officers

- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)

Company: https://www.keypedia.com/companies/meiji-seika-pharma-co-ltd/9f210099-6346-4340-9f86-521eb46b2629

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c